Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

SKU ID : QYR-15566770 | Publishing Date : 16-Apr-2020 | No. of pages : 117

Detailed TOC of Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

1 Study Coverage
    1.1 Acinetobacter Infections Treatment Product Introduction
    1.2 Market Segments
    1.3 Key Acinetobacter Infections Treatment Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type
        1.4.2 Sulbactam
        1.4.3 Carbapenems
        1.4.4 Aminoglycosides
        1.4.5 Polymyxins
        1.4.6 Tetracyclines
        1.4.7 Others
    1.5 Market by Application
        1.5.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Application
        1.5.2 ETX2514
        1.5.3 Nacubactam RG6080
        1.5.4 Arenicin
        1.5.5 VXD-001
        1.5.6 Small molecule antibiotic
        1.5.7 AR-401 mAB
        1.5.8 LCB01-0371 (PO)
        1.5.9 GN-4474
        1.5.10 Antibacterial Antibody
    1.6 Coronavirus Disease 2019 (Covid-19): Acinetobacter Infections Treatment Industry Impact
        1.6.1 How the Covid-19 is Affecting the Acinetobacter Infections Treatment Industry
            1.6.1.1 Acinetobacter Infections Treatment Business Impact Assessment - Covid-19
            1.6.1.2 Supply Chain Challenges
            1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
        1.6.2 Market Trends and Acinetobacter Infections Treatment Potential Opportunities in the COVID-19 Landscape
        1.6.3 Measures / Proposal against Covid-19
            1.6.3.1 Government Measures to Combat Covid-19 Impact
            1.6.3.2 Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
    1.7 Study Objectives
    1.8 Years Considered

2 Executive Summary
    2.1 Global Acinetobacter Infections Treatment Market Size Estimates and Forecasts
        2.1.1 Global Acinetobacter Infections Treatment Revenue 2015-2026
        2.1.2 Global Acinetobacter Infections Treatment Sales 2015-2026
    2.2 Acinetobacter Infections Treatment Market Size by Region: 2020 Versus 2026
        2.2.1 Global Acinetobacter Infections Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Acinetobacter Infections Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Acinetobacter Infections Treatment Competitor Landscape by Players
    3.1 Acinetobacter Infections Treatment Sales by Manufacturers
        3.1.1 Acinetobacter Infections Treatment Sales by Manufacturers (2015-2020)
        3.1.2 Acinetobacter Infections Treatment Sales Market Share by Manufacturers (2015-2020)
    3.2 Acinetobacter Infections Treatment Revenue by Manufacturers
        3.2.1 Acinetobacter Infections Treatment Revenue by Manufacturers (2015-2020)
        3.2.2 Acinetobacter Infections Treatment Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2019
        3.2.5 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Acinetobacter Infections Treatment Price by Manufacturers
    3.4 Acinetobacter Infections Treatment Manufacturing Base Distribution, Product Types
        3.4.1 Acinetobacter Infections Treatment Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Acinetobacter Infections Treatment Product Type
        3.4.3 Date of International Manufacturers Enter into Acinetobacter Infections Treatment Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
    4.1 Global Acinetobacter Infections Treatment Market Size by Type (2015-2020)
        4.1.1 Global Acinetobacter Infections Treatment Sales by Type (2015-2020)
        4.1.2 Global Acinetobacter Infections Treatment Revenue by Type (2015-2020)
        4.1.3 Acinetobacter Infections Treatment Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Acinetobacter Infections Treatment Market Size Forecast by Type (2021-2026)
        4.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2026)
        4.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Type (2021-2026)
        4.2.3 Acinetobacter Infections Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Acinetobacter Infections Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
    5.1 Global Acinetobacter Infections Treatment Market Size by Application (2015-2020)
        5.1.1 Global Acinetobacter Infections Treatment Sales by Application (2015-2020)
        5.1.2 Global Acinetobacter Infections Treatment Revenue by Application (2015-2020)
        5.1.3 Acinetobacter Infections Treatment Price by Application (2015-2020)
    5.2 Acinetobacter Infections Treatment Market Size Forecast by Application (2021-2026)
        5.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2026)
        5.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Application (2021-2026)
        5.2.3 Global Acinetobacter Infections Treatment Price Forecast by Application (2021-2026)

6 North America
    6.1 North America Acinetobacter Infections Treatment by Country
        6.1.1 North America Acinetobacter Infections Treatment Sales by Country
        6.1.2 North America Acinetobacter Infections Treatment Revenue by Country
        6.1.3 U.S.
        6.1.4 Canada
    6.2 North America Acinetobacter Infections Treatment Market Facts & Figures by Type
    6.3 North America Acinetobacter Infections Treatment Market Facts & Figures by Application

7 Europe
    7.1 Europe Acinetobacter Infections Treatment by Country
        7.1.1 Europe Acinetobacter Infections Treatment Sales by Country
        7.1.2 Europe Acinetobacter Infections Treatment Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 U.K.
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Acinetobacter Infections Treatment Market Facts & Figures by Type
    7.3 Europe Acinetobacter Infections Treatment Market Facts & Figures by Application

8 Asia Pacific
    8.1 Asia Pacific Acinetobacter Infections Treatment by Region
        8.1.1 Asia Pacific Acinetobacter Infections Treatment Sales by Region
        8.1.2 Asia Pacific Acinetobacter Infections Treatment Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Taiwan
        8.1.9 Indonesia
        8.1.10 Thailand
        8.1.11 Malaysia
        8.1.12 Philippines
        8.1.13 Vietnam
    8.2 Asia Pacific Acinetobacter Infections Treatment Market Facts & Figures by Type
    8.3 Asia Pacific Acinetobacter Infections Treatment Market Facts & Figures by Application

9 Latin America
    9.1 Latin America Acinetobacter Infections Treatment by Country
        9.1.1 Latin America Acinetobacter Infections Treatment Sales by Country
        9.1.2 Latin America Acinetobacter Infections Treatment Revenue by Country
        9.1.3 Mexico
        9.1.4 Brazil
        9.1.5 Argentina
    9.2 Central & South America Acinetobacter Infections Treatment Market Facts & Figures by Type
    9.3 Central & South America Acinetobacter Infections Treatment Market Facts & Figures by Application

10 Middle East and Africa
    10.1 Middle East and Africa Acinetobacter Infections Treatment by Country
        10.1.1 Middle East and Africa Acinetobacter Infections Treatment Sales by Country
        10.1.2 Middle East and Africa Acinetobacter Infections Treatment Revenue by Country
        10.1.3 Turkey
        10.1.4 Saudi Arabia
        10.1.5 UAE
    10.2 Middle East and Africa Acinetobacter Infections Treatment Market Facts & Figures by Type
    10.3 Middle East and Africa Acinetobacter Infections Treatment Market Facts & Figures by Application

11 Company Profiles
    11.1 Entasis Therapeutics
        11.1.1 Entasis Therapeutics Corporation Information
        11.1.2 Entasis Therapeutics Description, Business Overview and Total Revenue
        11.1.3 Entasis Therapeutics Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
        11.1.5 Entasis Therapeutics Recent Development
    11.2 Roche
        11.2.1 Roche Corporation Information
        11.2.2 Roche Description, Business Overview and Total Revenue
        11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 Roche Acinetobacter Infections Treatment Products Offered
        11.2.5 Roche Recent Development
    11.3 Adenium Biotech
        11.3.1 Adenium Biotech Corporation Information
        11.3.2 Adenium Biotech Description, Business Overview and Total Revenue
        11.3.3 Adenium Biotech Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 Adenium Biotech Acinetobacter Infections Treatment Products Offered
        11.3.5 Adenium Biotech Recent Development
    11.4 Vaxdyn
        11.4.1 Vaxdyn Corporation Information
        11.4.2 Vaxdyn Description, Business Overview and Total Revenue
        11.4.3 Vaxdyn Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Vaxdyn Acinetobacter Infections Treatment Products Offered
        11.4.5 Vaxdyn Recent Development
    11.5 Hsiri Therapeutics
        11.5.1 Hsiri Therapeutics Corporation Information
        11.5.2 Hsiri Therapeutics Description, Business Overview and Total Revenue
        11.5.3 Hsiri Therapeutics Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Products Offered
        11.5.5 Hsiri Therapeutics Recent Development
    11.6 Aridis Pharmaceuticals
        11.6.1 Aridis Pharmaceuticals Corporation Information
        11.6.2 Aridis Pharmaceuticals Description, Business Overview and Total Revenue
        11.6.3 Aridis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Products Offered
        11.6.5 Aridis Pharmaceuticals Recent Development
    11.7 LegoChem Biosciences
        11.7.1 LegoChem Biosciences Corporation Information
        11.7.2 LegoChem Biosciences Description, Business Overview and Total Revenue
        11.7.3 LegoChem Biosciences Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Products Offered
        11.7.5 LegoChem Biosciences Recent Development
    11.8 Atterx Biotherapeutics
        11.8.1 Atterx Biotherapeutics Corporation Information
        11.8.2 Atterx Biotherapeutics Description, Business Overview and Total Revenue
        11.8.3 Atterx Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
        11.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Products Offered
        11.8.5 Atterx Biotherapeutics Recent Development
    11.9 Achaogen
        11.9.1 Achaogen Corporation Information
        11.9.2 Achaogen Description, Business Overview and Total Revenue
        11.9.3 Achaogen Sales, Revenue and Gross Margin (2015-2020)
        11.9.4 Achaogen Acinetobacter Infections Treatment Products Offered
        11.9.5 Achaogen Recent Development
    11.10 Peptilogics
        11.10.1 Peptilogics Corporation Information
        11.10.2 Peptilogics Description, Business Overview and Total Revenue
        11.10.3 Peptilogics Sales, Revenue and Gross Margin (2015-2020)
        11.10.4 Peptilogics Acinetobacter Infections Treatment Products Offered
        11.10.5 Peptilogics Recent Development
    11.1 Entasis Therapeutics
        11.1.1 Entasis Therapeutics Corporation Information
        11.1.2 Entasis Therapeutics Description, Business Overview and Total Revenue
        11.1.3 Entasis Therapeutics Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
        11.1.5 Entasis Therapeutics Recent Development
    11.12 Shionogi
        11.12.1 Shionogi Corporation Information
        11.12.2 Shionogi Description, Business Overview and Total Revenue
        11.12.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
        11.12.4 Shionogi Products Offered
        11.12.5 Shionogi Recent Development
    11.13 Techulon
        11.13.1 Techulon Corporation Information
        11.13.2 Techulon Description, Business Overview and Total Revenue
        11.13.3 Techulon Sales, Revenue and Gross Margin (2015-2020)
        11.13.4 Techulon Products Offered
        11.13.5 Techulon Recent Development
    11.14 Tetraphase Pharmaceuticals
        11.14.1 Tetraphase Pharmaceuticals Corporation Information
        11.14.2 Tetraphase Pharmaceuticals Description, Business Overview and Total Revenue
        11.14.3 Tetraphase Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
        11.14.4 Tetraphase Pharmaceuticals Products Offered
        11.14.5 Tetraphase Pharmaceuticals Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Acinetobacter Infections Treatment Market Estimates and Projections by Region
        12.1.1 Global Acinetobacter Infections Treatment Sales Forecast by Regions 2021-2026
        12.1.2 Global Acinetobacter Infections Treatment Revenue Forecast by Regions 2021-2026
    12.2 North America Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
        12.2.1 North America: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
        12.2.2 North America: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
        12.2.3 North America: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
    12.3 Europe Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
        12.3.1 Europe: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
        12.3.2 Europe: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
        12.3.3 Europe: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Acinetobacter Infections Treatment Market Size Forecast by Region (2021-2026)
    12.5 Latin America Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
        12.5.1 Latin America: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
        12.5.2 Latin America: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
        12.5.3 Latin America: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Acinetobacter Infections Treatment Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Acinetobacter Infections Treatment Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Acinetobacter Infections Treatment Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Acinetobacter Infections Treatment Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter’s Five Forces Analysis
    13.5 Primary Interviews with Key Acinetobacter Infections Treatment Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Acinetobacter Infections Treatment Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details

List of Figures, Tables and Charts Available in Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

List of Tables
    Table 1. Acinetobacter Infections Treatment Market Segments
    Table 2. Ranking of Global Top Acinetobacter Infections Treatment Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type 2020-2026 (Cases) & (US$ Million)
    Table 4. Major Manufacturers of Sulbactam
    Table 5. Major Manufacturers of Carbapenems
    Table 6. Major Manufacturers of Aminoglycosides
    Table 7. Major Manufacturers of Polymyxins
    Table 8. Major Manufacturers of Tetracyclines
    Table 9. Major Manufacturers of Others
    Table 10. COVID-19 Impact Global Market: (Four Acinetobacter Infections Treatment Market Size Forecast Scenarios)
    Table 11. Opportunities and Trends for Acinetobacter Infections Treatment Players in the COVID-19 Landscape
    Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 13. Key Regions/Countries Measures against Covid-19 Impact
    Table 14. Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
    Table 15. Global Acinetobacter Infections Treatment Market Size Growth Rate by Application 2020-2026 (Cases)
    Table 16. Global Acinetobacter Infections Treatment Market Size by Region (Cases) & (US$ Million): 2020 VS 2026
    Table 17. Global Acinetobacter Infections Treatment Sales by Regions 2015-2020 (Cases)
    Table 18. Global Acinetobacter Infections Treatment Sales Market Share by Regions (2015-2020)
    Table 19. Global Acinetobacter Infections Treatment Revenue by Regions 2015-2020 (US$ Million)
    Table 20. Global Acinetobacter Infections Treatment Sales by Manufacturers (2015-2020) (Cases)
    Table 21. Global Acinetobacter Infections Treatment Sales Share by Manufacturers (2015-2020)
    Table 22. Global Acinetobacter Infections Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 23. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2019)
    Table 24. Acinetobacter Infections Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 25. Acinetobacter Infections Treatment Revenue Share by Manufacturers (2015-2020)
    Table 26. Key Manufacturers Acinetobacter Infections Treatment Price (2015-2020) (USD/Case)
    Table 27. Acinetobacter Infections Treatment Manufacturers Manufacturing Base Distribution and Headquarters
    Table 28. Manufacturers Acinetobacter Infections Treatment Product Type
    Table 29. Date of International Manufacturers Enter into Acinetobacter Infections Treatment Market
    Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 31. Global Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 32. Global Acinetobacter Infections Treatment Sales Share by Type (2015-2020)
    Table 33. Global Acinetobacter Infections Treatment Revenue by Type (2015-2020) (US$ Million)
    Table 34. Global Acinetobacter Infections Treatment Revenue Share by Type (2015-2020)
    Table 35. Acinetobacter Infections Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Case)
    Table 36. Global Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 37. Global Acinetobacter Infections Treatment Sales Share by Application (2015-2020)
    Table 38. North America Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
    Table 39. North America Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
    Table 40. North America Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
    Table 41. North America Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
    Table 42. North America Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 43. North America Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Table 44. North America Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 45. North America Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Table 46. Europe Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
    Table 47. Europe Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
    Table 48. Europe Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
    Table 49. Europe Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
    Table 50. Europe Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 51. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Table 52. Europe Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 53. Europe Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Table 54. Asia Pacific Acinetobacter Infections Treatment Sales by Region (2015-2020) (Cases)
    Table 55. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
    Table 56. Asia Pacific Acinetobacter Infections Treatment Revenue by Region (2015-2020) (US$ Million)
    Table 57. Asia Pacific Acinetobacter Infections Treatment Revenue Market Share by Region (2015-2020)
    Table 58. Asia Pacific Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 59. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Table 60. Asia Pacific Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 61. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Table 62. Latin America Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
    Table 63. Latin America Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
    Table 64. Latin Americaa Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
    Table 65. Latin America Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
    Table 66. Latin America Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 67. Latin America Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Table 68. Latin America Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 69. Latin America Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Table 70. Middle East and Africa Acinetobacter Infections Treatment Sales by Country (2015-2020) (Cases)
    Table 71. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Country (2015-2020)
    Table 72. Middle East and Africa Acinetobacter Infections Treatment Revenue by Country (2015-2020) (US$ Million)
    Table 73. Middle East and Africa Acinetobacter Infections Treatment Revenue Market Share by Country (2015-2020)
    Table 74. Middle East and Africa Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
    Table 75. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Table 76. Middle East and Africa Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
    Table 77. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Table 78. Entasis Therapeutics Corporation Information
    Table 79. Entasis Therapeutics Description and Major Businesses
    Table 80. Entasis Therapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 81. Entasis Therapeutics Product
    Table 82. Entasis Therapeutics Recent Development
    Table 83. Roche Corporation Information
    Table 84. Roche Description and Major Businesses
    Table 85. Roche Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 86. Roche Product
    Table 87. Roche Recent Development
    Table 88. Adenium Biotech Corporation Information
    Table 89. Adenium Biotech Description and Major Businesses
    Table 90. Adenium Biotech Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 91. Adenium Biotech Product
    Table 92. Adenium Biotech Recent Development
    Table 93. Vaxdyn Corporation Information
    Table 94. Vaxdyn Description and Major Businesses
    Table 95. Vaxdyn Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 96. Vaxdyn Product
    Table 97. Vaxdyn Recent Development
    Table 98. Hsiri Therapeutics Corporation Information
    Table 99. Hsiri Therapeutics Description and Major Businesses
    Table 100. Hsiri Therapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 101. Hsiri Therapeutics Product
    Table 102. Hsiri Therapeutics Recent Development
    Table 103. Aridis Pharmaceuticals Corporation Information
    Table 104. Aridis Pharmaceuticals Description and Major Businesses
    Table 105. Aridis Pharmaceuticals Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 106. Aridis Pharmaceuticals Product
    Table 107. Aridis Pharmaceuticals Recent Development
    Table 108. LegoChem Biosciences Corporation Information
    Table 109. LegoChem Biosciences Description and Major Businesses
    Table 110. LegoChem Biosciences Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 111. LegoChem Biosciences Product
    Table 112. LegoChem Biosciences Recent Development
    Table 113. Atterx Biotherapeutics Corporation Information
    Table 114. Atterx Biotherapeutics Description and Major Businesses
    Table 115. Atterx Biotherapeutics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 116. Atterx Biotherapeutics Product
    Table 117. Atterx Biotherapeutics Recent Development
    Table 118. Achaogen Corporation Information
    Table 119. Achaogen Description and Major Businesses
    Table 120. Achaogen Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 121. Achaogen Product
    Table 122. Achaogen Recent Development
    Table 123. Peptilogics Corporation Information
    Table 124. Peptilogics Description and Major Businesses
    Table 125. Peptilogics Acinetobacter Infections Treatment Production (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 126. Peptilogics Product
    Table 127. Peptilogics Recent Development
    Table 128. Sealife PHARMA Corporation Information
    Table 129. Sealife PHARMA Description and Major Businesses
    Table 130. Sealife PHARMA Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 131. Sealife PHARMA Product
    Table 132. Sealife PHARMA Recent Development
    Table 133. Shionogi Corporation Information
    Table 134. Shionogi Description and Major Businesses
    Table 135. Shionogi Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 136. Shionogi Product
    Table 137. Shionogi Recent Development
    Table 138. Techulon Corporation Information
    Table 139. Techulon Description and Major Businesses
    Table 140. Techulon Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 141. Techulon Product
    Table 142. Techulon Recent Development
    Table 143. Tetraphase Pharmaceuticals Corporation Information
    Table 144. Tetraphase Pharmaceuticals Description and Major Businesses
    Table 145. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (US$ Million), Price (USD/Case) and Gross Margin (2015-2020)
    Table 146. Tetraphase Pharmaceuticals Product
    Table 147. Tetraphase Pharmaceuticals Recent Development
    Table 148. Global Acinetobacter Infections Treatment Sales Forecast by Regions (2021-2026) (Cases)
    Table 149. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Regions (2021-2026)
    Table 150. Global Acinetobacter Infections Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
    Table 151. Global Acinetobacter Infections Treatment Revenue Market Share Forecast by Regions (2021-2026)
    Table 152. North America: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
    Table 153. North America: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 154. Europe: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
    Table 155. Europe: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 156. Asia Pacific: Acinetobacter Infections Treatment Sales Forecast by Region (2021-2026) (Cases)
    Table 157. Asia Pacific: Acinetobacter Infections Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 158. Latin America: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
    Table 159. Latin America: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 160. Middle East and Africa: Acinetobacter Infections Treatment Sales Forecast by Country (2021-2026) (Cases)
    Table 161. Middle East and Africa: Acinetobacter Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
    Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 163. Key Challenges
    Table 164. Market Risks
    Table 165. Main Points Interviewed from Key Acinetobacter Infections Treatment Players
    Table 166. Acinetobacter Infections Treatment Customers List
    Table 167. Acinetobacter Infections Treatment Distributors List
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acinetobacter Infections Treatment Product Picture
    Figure 2. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2020 & 2026
    Figure 3. Sulbactam Product Picture
    Figure 4. Carbapenems Product Picture
    Figure 5. Aminoglycosides Product Picture
    Figure 6. Polymyxins Product Picture
    Figure 7. Tetracyclines Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Acinetobacter Infections Treatment Sales Market Share by Application in 2020 & 2026
    Figure 10. ETX2514
    Figure 11. Nacubactam RG6080
    Figure 12. Arenicin
    Figure 13. VXD-001
    Figure 14. Small molecule antibiotic
    Figure 15. AR-401 mAB
    Figure 16. LCB01-0371 (PO)
    Figure 17. GN-4474
    Figure 18. Antibacterial Antibody
    Figure 19. Acinetobacter Infections Treatment Report Years Considered
    Figure 20. Global Acinetobacter Infections Treatment Market Size 2015-2026 (US$ Million)
    Figure 21. Global Acinetobacter Infections Treatment Sales 2015-2026 (Cases)
    Figure 22. Global Acinetobacter Infections Treatment Market Size Market Share by Region: 2020 Versus 2026
    Figure 23. Global Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
    Figure 24. Global Acinetobacter Infections Treatment Sales Market Share by Region in 2019
    Figure 25. Global Acinetobacter Infections Treatment Revenue Market Share by Region (2015-2020)
    Figure 26. Global Acinetobacter Infections Treatment Revenue Market Share by Region in 2019
    Figure 27. Global Acinetobacter Infections Treatment Sales Share by Manufacturer in 2019
    Figure 28. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2019
    Figure 29. Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 30. Global Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
    Figure 31. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2019
    Figure 32. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2015-2020)
    Figure 33. Global Acinetobacter Infections Treatment Revenue Market Share by Type in 2019
    Figure 34. Global Acinetobacter Infections Treatment Market Share by Price Range (2015-2020)
    Figure 35. Global Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
    Figure 36. Global Acinetobacter Infections Treatment Sales Market Share by Application in 2019
    Figure 37. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2015-2020)
    Figure 38. Global Acinetobacter Infections Treatment Revenue Market Share by Application in 2019
    Figure 39. North America Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
    Figure 40. North America Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 41. North America Acinetobacter Infections Treatment Sales Market Share by Country in 2019
    Figure 42. North America Acinetobacter Infections Treatment Revenue Market Share by Country in 2019
    Figure 43. U.S. Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 44. U.S. Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. Canada Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 46. Canada Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. North America Acinetobacter Infections Treatment Market Share by Type in 2019
    Figure 48. North America Acinetobacter Infections Treatment Market Share by Application in 2019
    Figure 49. Europe Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
    Figure 50. Europe Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 51. Europe Acinetobacter Infections Treatment Sales Market Share by Country in 2019
    Figure 52. Europe Acinetobacter Infections Treatment Revenue Market Share by Country in 2019
    Figure 53. Germany Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 54. Germany Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. France Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 56. France Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. U.K. Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 58. U.K. Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Italy Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 60. Italy Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Russia Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 62. Russia Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 63. Europe Acinetobacter Infections Treatment Market Share by Type in 2019
    Figure 64. Europe Acinetobacter Infections Treatment Market Share by Application in 2019
    Figure 65. Asia Pacific Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
    Figure 66. Asia Pacific Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 67. Asia Pacific Acinetobacter Infections Treatment Sales Market Share by Region in 2019
    Figure 68. Asia Pacific Acinetobacter Infections Treatment Revenue Market Share by Region in 2019
    Figure 69. China Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 70. China Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Japan Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 72. Japan Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. South Korea Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 74. South Korea Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. India Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 76. India Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Australia Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 78. Australia Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. Taiwan Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 80. Taiwan Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Indonesia Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 82. Indonesia Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 83. Thailand Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 84. Thailand Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 85. Malaysia Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 86. Malaysia Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 87. Philippines Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 88. Philippines Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 89. Vietnam Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 90. Vietnam Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 91. Asia Pacific Acinetobacter Infections Treatment Market Share by Type in 2019
    Figure 92. Asia Pacific Acinetobacter Infections Treatment Market Share by Application in 2019
    Figure 93. Latin America Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
    Figure 94. Latin America Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 95. Latin America Acinetobacter Infections Treatment Sales Market Share by Country in 2019
    Figure 96. Latin America Acinetobacter Infections Treatment Revenue Market Share by Country in 2019
    Figure 97. Mexico Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 98. Mexico Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 99. Brazil Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 100. Brazil Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 101. Argentina Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 102. Argentina Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 103. Latin America Acinetobacter Infections Treatment Market Share by Type in 2019
    Figure 104. Latin America Acinetobacter Infections Treatment Market Share by Application in 2019
    Figure 105. Middle East and Africa Acinetobacter Infections Treatment Sales Growth Rate 2015-2020 (Cases)
    Figure 106. Middle East and Africa Acinetobacter Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 107. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Country in 2019
    Figure 108. Middle East and Africa Acinetobacter Infections Treatment Revenue Market Share by Country in 2019
    Figure 109. Turkey Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 110. Turkey Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 111. Saudi Arabia Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 112. Saudi Arabia Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 113. UAE Acinetobacter Infections Treatment Sales Growth Rate (2015-2020) (Cases)
    Figure 114. UAE Acinetobacter Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 115. Middle East and Africa Acinetobacter Infections Treatment Market Share by Type in 2019
    Figure 116. Middle East and Africa Acinetobacter Infections Treatment Market Share by Application in 2019
    Figure 117. Entasis Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 118. Roche Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 119. Adenium Biotech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 120. Vaxdyn Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 121. Hsiri Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 122. Aridis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 123. LegoChem Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 124. Atterx Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 125. Achaogen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 126. Peptilogics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 127. Sealife PHARMA Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 128. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 129. Techulon Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 130. Tetraphase Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 131. North America Acinetobacter Infections Treatment Sales Growth Rate Forecast (2021-2026) (Cases)
    Figure 132. North America Acinetobacter Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 133. Europe Acinetobacter Infections Treatment Sales Growth Rate Forecast (2021-2026) (Cases)
    Figure 134. Europe Acinetobacter Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 135. Asia Pacific Acinetobacter Infections Treatment Sales Growth Rate Forecast (2021-2026) (Cases)
    Figure 136. Asia Pacific Acinetobacter Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 137. Latin America Acinetobacter Infections Treatment Sales Growth Rate Forecast (2021-2026) (Cases)
    Figure 138. Latin America Acinetobacter Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 139. Middle East and Africa Acinetobacter Infections Treatment Sales Growth Rate Forecast (2021-2026) (Cases)
    Figure 140. Middle East and Africa Acinetobacter Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
    Figure 141. Porter's Five Forces Analysis
    Figure 142. Channels of Distribution
    Figure 143. Distributors Profiles
    Figure 144. Bottom-up and Top-down Approaches for This Report
    Figure 145. Data Triangulation
    Figure 146. Key Executives Interviewed

Keyplayers in Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals

Request Sample

Pre-order Enquiry

Request Discount

Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

Detailed TOC of Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

List of Figures, Tables and Charts Available in Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

Keyplayers in Global Acinetobacter Infections Treatment Market Insights, Forecast to 2026

Our Clients